Fluorizoparib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fluorizoparib, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced Breast Cancer [Phase 3]